Matthew P. Young
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew P. Young
Matthew P. Young is recorded as CFO at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $3,583,378 for Matthew P. Young in fiscal 2019, including a base salary of $601,253. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jazz Pharmaceuticals plc
Other people whose current roles at this company are on record from its filings.
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $601,253 | $3,583,378 |
| 2018 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $575,385 | $3,356,337 |
| 2017 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $545,385 | $3,292,653 |
Recent activity
No call appearances or filed executive changes recorded yet.